Glenmede Investment Management, LP Abb Vie Inc. Transaction History
Glenmede Investment Management, LP
- $20 Billion
- Q3 2025
A detailed history of Glenmede Investment Management, LP transactions in Abb Vie Inc. stock. As of the latest transaction made, Glenmede Investment Management, LP holds 340,243 shares of ABBV stock, worth $79.1 Million. This represents 0.39% of its overall portfolio holdings.
Number of Shares
340,243
Previous 355,906
4.4%
Holding current value
$79.1 Million
Previous $66.1 Billion
99.88%
% of portfolio
0.39%
Previous 0.33%
Shares
2 transactions
Others Institutions Holding ABBV
# of Institutions
4,473Shares Held
1.28BCall Options Held
16.3MPut Options Held
12.5M-
Vanguard Group Inc Valley Forge, PA178MShares$41.3 Billion0.64% of portfolio
-
Black Rock Inc. New York, NY136MShares$31.7 Billion0.54% of portfolio
-
State Street Corp Boston, MA79.8MShares$18.5 Billion0.66% of portfolio
-
Jpmorgan Chase & CO New York, NY56.5MShares$13.1 Billion0.86% of portfolio
-
Morgan Stanley New York, NY41.7MShares$9.68 Billion0.61% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $411B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...